DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

Wells Fargo Maintains Overweight on Karuna Therapeutics, Raises Price Target to $137

Wells Fargo maintains Karuna Therapeutics (NASDAQ:KRTX) with a Overweight and raises the price target from $106 to $137.

Benzinga · 01/22/2020 14:58

Wells Fargo maintains Karuna Therapeutics (NASDAQ:KRTX) with a Overweight and raises the price target from $106 to $137.